Therapies

IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator

12 days ago   |   By Xconomy

IFM Therapeutics has raised $55.5 million to launch its third drug subsidiary as well as an incubator, both of which are focused on developing new therapies for inflammatory diseases and cancers. Those endeavors will be led by a familiar face. Boston-based IFM has promoted its vice president of research and development, Martin Seidel, to become its CEO and a member of the board of directors. Gary Glick, IFM's co-founder and CEO since its formation two years ago , is taking on a new role as executive chairman of the board. IFM Therapeutics operates a business structure that houses its...
Read more ...

 


Search by Tags

   Therapies      Drugs      Discovery      Cancer      Therapeutics      Drug      Research      Boston      Boston blog main      Boston top stories      National blog main      National top stories      New York blog main      New York top stories      Abingworth      Atlas Venture      Autoimmune Diseases      Biotech      Cancer      Deals      Gary Glick      IFM Therapeutics      Inflammatory Diseases      Investing      Life Sciences      Martin Seidel      Novartis      Omega Funds      Startups      Venture Capital  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Subsequent Use of a Pressure Sensor to Record Intra-abdominal Pressure after...

Subsequent Use of a Pressure Sensor to Record Intra-abdominal Pressure after Maximum Vaginal Closure Force in a Clinical Trial

Stefan Niederauer , Brian Cottle , Xiaoming Sheng , James Ashton-Miller , John DeLancey , Robert Hitchcock Early Access Note: Early Access articles are new content made... Read more ...

Bio Roundup: Sarepta's Approval, Merck M&A, Drug Price Bill & More

Bio Roundup: Sarepta's Approval, Merck M&A, Drug Price Bill & More

If you're keeping track, FDA drug approvals have been on a tear in the past month with several decisions coming well ahead of their targeted dates. And then there's Sarepta... Read more ...

An Automated Framework for Large scale Retrospective Analysis of Ultrasound...

An Automated Framework for Large scale Retrospective Analysis of Ultrasound Images

Pradeeba Sridar , Ashnil Kumar , Ann Quinton , Narelle June Kennedy , Ralph Nanan , Jinman Kim Early Access Note: Early Access articles are new content made available in... Read more ...

IAmScience Madison Green

IAmScience Madison Green

By Mariah Cox | Bond LSC It's hard for a sixth-grader to nail down exactly what she wants to do for the rest of her life, but that's when the process started for Madison Green... Read more ...

Focusing on Research in Departmental Honors Program

Focusing on Research in Departmental Honors Program

The Department of Biological and Agricultural Engineering participates in the College of Engineering Honors Program, geared towards high achieving students looking for... Read more ...

Amarin's Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk

Amarin's Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk

A prescription pill derived from fish-oil pill received the regulatory nod Friday to expand its use as a supplementary treatment, alongside statins, to more patients at risk of... Read more ...

Biotech Briefing: Illumina Spin-out Verogen Buys GEDmatch

Reports + Research Illumina Spin-out Verogen Buys GEDmatch GEDmatch, a genealogy website, was launched from obscurity for its role in helping catch the Golden State Killer-a... Read more ...

AveXis Inc.: Senior Manager, Data Integrity

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego... Read more ...

Vireo: Bayesian demultiplexing of pooled single-cell RNA-seq data without...

Multiplexed single-cell RNA-seq analysis of multiple samples using pooling is a promising experimental design, offering increased throughput while allowing to overcome batch... Read more ...

Application of Raman Spectroscopy in Monoclonal Antibody Producing...

Abstract Monoclonal antibodies are biopharmaceuticals produced by mammalian cell lines in bioreactors at a variety of scales. Cell engineering, media optimization, process... Read more ...